Search

Our Science

You are here: Home / About us / Our Science

Horizon’s science base draws upon a 20 year heritage in oncology research, translational medicine and genome-editing. This heritage is the basis of Horizon’s expertise in translational genomics that has led to the development of rAAV gene-editing, a proprietary genome-editing platform based on the unique ability of rAAV vectors to stimulate homologous recombination. By exploiting a cell’s natural means of repairing its own DNA in an error-free manner, rAAV enables the precise insertion, deletion, substitution of a desired DNA sequence into any endogenous gene loci in any mammalian cell.

In 2013 Horizon expanded the range of its gene-editing capabilities through the in-licensing of nuclease technologies, which are ideally suited for the efficient and cost effective generation of knockouts. 

Discover Our Science

Explore to learn more

Publications

Explore to learn more

Login Error


There was an error with your login - please try again.

Forgotten your password? Click here

OK ×

Recover your password

Please enter your email address and we'll send you a reset link

×

Thank you.


We've sent you an email to reset your password.

OK ×

Add Voucher


Sorry, Unable to add voucher

OK ×

Account Error


There was an error updating your details.

OK ×

Thank you.


Your changes have been saved.

OK ×

Thank you


Thank you for registering to the Horizon Discovery website. We hope you enjoy and benefit from our online resources, and please feel free to contact us if you have any queries or feedback through the website itself or at info@horizondiscovery.com.


Got a few seconds to tell us what you're interested in?



Tick all that apply:

Horizon’s Offerings

Application Area

Disease Area

 

Other Disease Area (Please specify)


OK
×

Thank you.


Items have been saved to your basket.

OK ×